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Objective: The aim of this study was to estimate nationally representative prevalence rates of amphetamine-
type stimulant (ATS) use and to identify consumption-associated factors, proposing a conditional model of
direct and indirect consumption paths.
Method: Using data from the Second Brazilian National Alcohol and Drugs Survey, this cross-sectional
study analyzed a subsample of 3,828 participants between 15 and 64 years old, gathering information on
the use of psychoactive substances in a probabilistic sample of the Brazilian household population.
Results: Rates of lifetime and last-year ATS use were, respectively, 4.1 and 1.6%. Economically
privileged individuals and users of other substances were more at risk for using ATS. The results
suggest that higher education decreases the chances of ATS consumption. The conditional model
showed that higher income increased ATS use, higher education lowered the odds of such an
increase, and cocaine use cancelled that associative effect.
Conclusion: Brazil presents high rates of ATS use. Prevention and treatment strategies should focus
on the protective effect of higher education levels and should target polydrug use. Knowledge of ATS-
associated factors and user profiles is the starting point for developing effective treatments and
tailored prevention strategies.
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Introduction
Amphetamine-type stimulants (ATS) are a group of synthetic
drugs that includes amphetamine and methamphetamine,
as well as other substances, such as cathinones, methcathi-
none, fenethylline, ephedrine, pseudoephedrine, methylphe-
nidate, and 3,4-methylenedioxymethamphetamine (MDMA,
or ‘‘ecstasy’’), some of which are legally produced, purchased,
and used.1 The global proliferation of new synthetic drugs,
also known as new psychoactive substances (NPS) is
challenging pre-established mechanisms of access and
policy control.2 It is worrisome how fast and easily these
new substances are being designed and produced, placing
the recreational drug industry a step ahead of judicial
authorities and drug control agencies.3
Recent reports indicate ATS usage rates of 0.5 and
0.6% in Europe and North America, respectively.4,5 Data
on ATS consumption in Latin America are scarce, deriv-
ing mostly from police arrest reports, which are usually
inaccurate. Nevertheless, according to the most recent
United Nations Office on Drugs and Crime (UNODC)
Latin American ATS Assessment, this class of drugs is
one of the most widely used in the region, second only to
cannabis.1
To date, estimations of ATS consumption in Brazil have
been limited to specific populations, such as students6,7
and professional drivers,8 with recent studies indicating
increased consumption in these populations.8,9 Despite
the large body of evidence showing the addictive and
neurotoxic proprieties of most drugs belonging to the ATS
class,10 the general perception of users is that these
drugs are less harmful than others, and the damage
to physical, mental, and social health2 is, therefore,
frequently underestimated.10,11 Some of the health con-
sequences of ATS use are sleep disorders, psychosis,
paranoid hallucination, agitation, confusion, severe panic,
anxiety, depression, irregular heartbeat, tremors, muscle
cramps and decreased capacity to cope with changing
ambient temperature (which may result in hypo- or
hyperthermia), including the risk of death.2,4,10 Addition-
ally, the negative cognitive effects of ATS have been the
subject of recent studies.12 Worse still is the fact that ATS
consumers are usually polydrug users,11 thus increasing
their health risks, such as sexual risk behaviors, which
might lead to unfavorable outcomes.13 In addition, previous
studies have shown that socioeconomic and demographic
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characteristics can also have an impact on ATS consump-
tion, acting either as protective factors against or risk
factors for drug use and the development of addiction.14
This class of drug is still expensive compared to other
stimulants such as cocaine,15 which is generally more
available and cheaper in Brazil, leading to a higher chance
of concomitant use. Furthermore, it is expected that higher
education would decrease the chance of illicit drug use.14
Taking into account this body of evidence, the aim of
this study was to propose a conditional path model for
estimating the direct effect of income on ATS use in the
country, exploring the role that education level and cocaine
use play in the indirect path of this relationship. The study
also provides national rates and investigates factors asso-
ciated with ATS use in the country. Knowledge of the paths
leading to ATS use is crucial to the development of tailored
prevention strategies and treatment policies.1,16
Materials and methods
Sampling and procedures
The Second Brazilian National Alcohol and Drugs Survey
(BNADS II), conducted in 2012, used a multistage cluster
sampling procedure to select 4,607 individuals aged
14 years old or older – including an oversample of 1,157
adolescents – from the Brazilian household population.
Brazilian residents who do not speak Portuguese (e.g.,
in isolated tribes) and individuals with severe intellectual
disability were excluded from the sample. The overall
response rate was 77%, with 79% in the oversample of
adolescents. The BNADS II sampling17 involved four
stages: the selection of 149 counties using probability-
proportional-to-size methods; the selection of 375 total
census sectors from within those counties, also using
probability-proportional-to-size methods; the selection of
8 households within each census sector by simple random
sampling; and, finally, the selection of one member of
each household to be interviewed by the next-birthday
method. Trained interviewers conducted face-to-face
interviews of approximately one hour in the home of the
respondent, using a standardized questionnaire. Metho-
dological improvements over the BNADS I were imple-
mented to avoid the underreporting of illicit drug use and
to expand the list of evaluated substances. In BNADS II,
the questionnaire’s illicit drug use section was completed
in a separate room by the participant, who then returned
it to the interviewer in a sealed envelope. That change
confounds comparisons between the two measurements
(2006 and 2012) of illicit drug use rates. Additional details
regarding the methodology employed in the BNADS II are
available elsewhere.18,19
Measurements
Socioeconomic and demographic variables
In the present study, we evaluated a subsample of
individuals between 15 and 64 years of age (n=3,828) to
allow comparisons with other studies in the literature. Socio-
economic and demographic variables (sex, age, education
level, marital status, and personal income) were ana-
lyzed. Rates were also estimated for the five major
geographic regions of Brazil.
Substance use assessment
We assessed self-reported lifetime and past-year use of
ATS-class substances. Within the ATS class, we included
questions about amphetamine, crystal meth, methyl-
phenidate, ecstasy and other MDMA-derivative use, as
well as non-prescribed snorted methylphenidate (Ritalin).
The decision to combine these substances into a single
variable was made, in the first place, to allow national
comparisons with the UNODC data,2 which combines
these drugs into an ATS category, although a new class
called NPS in under consideration, which would act as an
umbrella category for all newly-developed drugs, whether
stimulants or not.
We also assessed the self-reported lifetime and past-
year use of other substances, including alcohol, tobacco,
cannabis, cocaine (snorted or smoked), hallucinogenic
drugs (such as lysergic acid diethylamide and psilocybin
mushrooms), anesthetic drugs (such as ketamine and
gamma-hydroxybutyrate), and tranquilizers (benzodiazepines).
In order to guarantee confidentiality, the drug-related
questions were not asked face-to-face but were answered
in private by each participant and returned at the end of
the interview in a sealed envelope, which was immedi-
ately sealed in a bag in front of the respondent. Alcohol
use disorder was assessed according to DSM-5 criteria.20
Control variables
Multivariate models included sex, age, and education
level as control variables. The conditional model included
sex and age as control variables.
Statistical analysis
All descriptive and multivariate models were run in STATA
version 13.0.21 Prevalence rates were estimated using
data weighted to correct for unequal probabilities of sample
selection, and a post-stratification weight was applied to
correct for non-responses and to adjust both samples to
known population distributions of demographic variables
(education level, age, sex, and region), according to the
2010 Brazilian Census.22 Cross-tabulations were used in
order to examine lifetime and last-year ATS consumption
rates across different socioeconomic and demographic
characteristics by sex. Prevalence rates of alcohol use
disorder, cannabis use, cocaine use, and the use of other
illicit substances were also estimated, both in the sample
as a whole and among ATS users. An exploratory multi-
variate analysis was performed with linear and logistic
regression models to assess the unconditional associa-
tions between ATS use and the outcomes of interest while
controlling for other socioeconomic demographic factors.
The conditional analysis was performed using PRO-
CESS macro, version 2.16 (processmacro.org) for SPSS
version 21.0. PROCESS macro is a computational pro-
cedure that implements moderation or mediation analysis
Rev Bras Psiquiatr. 2017;39(3)
202 LTS Massaro et al.
(or a combination of the two) in an integrated conditional
process model (i.e., moderations).23 To test the modera-
tion model as a hypothesis, we used the analytic method
discussed by Preacher and Preacher et al.,24,25 adopt-
ing an algorithm for conditional process analysis.23 The
moderation effects were estimated in PROCESS macro
using a maximum likelihood estimator. Bias-corrected
bootstrapping confidence intervals with 10,000 bootstrap
samples were used to test the null hypothesis (i.e., that
the indirect effect of cocaine use on ATS use is not
significant), which did not take sample weighting into
account. When confidence intervals contained zero, the
null hypothesis was accepted.26 All models were evaluated
using multiple indices of model fit27: a non-significant chi-
square statistic, comparative fit index values greater than
0.95, and standardized root mean square residual values
less than 0.08.
Results
Amphetamine-type stimulant use
Lifetime ATS use was reported by 4.1% of the individuals
in the sample (4.5% of the women and 3.8% of the men),
as shown in Table 1. The use of ATS in the last 12 months
(last-year ATS use) was reported by 1.6% of the indi-
viduals in the sample (2.2% of the women and 1.1% of
the men). The prevalence of lifetime and last-year ATS
use was lower among inhabitants of rural areas. The ATS
use rates were significantly higher in the central-west
region than in the four other major regions of Brazil (the
north, northeast, southeast, and south), reaching 9.0 and
4.6% for lifetime and last-year use, respectively (po 0.05;
Table 1).
Preliminary analysis of factors associated with ATS use
Our preliminary results showed a significant association
between income and last-year ATS use, in which the
chance of using ATS were approximately 5 times greater
for individuals in the highest income bracket than for
those in the lowest income bracket (Table 2). The pre-
liminary multivariate analysis also identified that the
higher the education level, the lower the risk of ATS
use. Last-year ATS use was positively associated with the
use of all other illicit substances. Users of ATS were 7.07
times more likely to use cannabis, 7.68 times more likely
to use other illegal substances and 21.31 times more
likely to use cocaine or crack than non-ATS users. There
was no significant association between ATS use and
alcohol use disorder.
Path models for ATS consumption
In the preliminary multivariate regression models, after
adjustments for all other socioeconomic and demographic
characteristics, illicit drug use, cannabis and cocaine use
were associated with ATS use, whereas education level
lowered the chances of such use. Among all possible com-
binations of direct and indirect effects of these variables
with ATS use, the best goodness-of-fit was shown by
cocaine use and education as concomitant moderators of
the direct effect of income on ATS use. The predictive
power of this model was estimated using R2 methods to
determine goodness-of-fit (i.e., the McFadden, Cox &
Snell, and Nagelkerke methods),28 resulting in satisfac-
tory values of 0.138, 0.019, and 0.1466, respectively.
As shown in Figure 1, education level and cocaine use
moderated the effect size of income on ATS use. In other
words, the chance of using ATS significantly decreased
with a high education level (X 13 years of schooling). The
conditional model analysis showed (Table 3) a significant
odds reduction with education level for the two quartiles
of years of schooling – 9.5 years (effect, 0.0004; 95%CI
0.0002-0.0007) and 19.5 years (effect, 0.0004; 95%CI
0.0002-0.0006) – provided the value of the second
moderator (cocaine use) was 0 (null). However, when
the second moderator value was 1 (concomitant cocaine
use), the association with education level ceased to be
significant. In other words, education level had no effect
on the magnitude of the direct effect between income and
ATS use when cocaine use was concurrent. All association
models were adjusted for sex and age. The same model
was not valid when cocaine use was replaced by cannabis
use or other illicit drug use as possible moderators.
Discussion
The use of ATS is a new issue in Brazil and has yet to
be fully investigated. Our results indicate that 1.6% of a
representative sample of the Brazilian population had
used at least one ATS in the last year. Given the popu-
lation size,29 this suggests that 3 million Brazilians used
ATS in the 12 months prior to the survey. This indicates
an enormous drug market and a potentially heavy burden
on Brazilian society. This prevalence surpasses the 1%
reported for Latin America in the latest UNODC study.1
In fact, it is higher than the prevalence reported for all
other Latin American countries (e.g., approximately 1.0%
for Costa Rica, 0.67% for Colombia, and 0.5% for Bolivia),
as well as for most European countries, where the average
consumption rate is 0.6%.2,30
The prevalence estimated in our study follows a trend
detected in another survey conducted in Brazil,31,32 which
demonstrated a twofold increase (from 0.3 to 0.7%) in
amphetamine consumption between 2001 and 2005. In
fact, the UNODC recently issued a warning about the
increased use of stimulants in low- and middle-income
countries, which are considered the preferred targets of
organized crime groups involved in the ATS trade. The
increased demand for ATS in such countries is probably
associated with their emerging economies and young
populations. Ecstasy-related arrests are also on the rise
in Brazil, accounting for 47% of all ATS-related arrests
between 2008 and 2012 in South America, Central
America, and the Caribbean.1
The high prevalence of ATS consumption among women
should also be highlighted. Stimulant misuse among
women has previously been studied in Brazil,33 and our
estimations corroborate those of a 2009 survey of college
students, which estimated that the rates of lifetime ATS
Rev Bras Psiquiatr. 2017;39(3)
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consumption were higher among women.7 The high
prevalence of ATS use among women is a cause for
concern, because it is known that heavy consumption
patterns and symptoms of dependence are more rapidly
established in women than men, and that the rates of
relapse after one or more periods of abstinence are
higher among women than men,34 which demonstrates
the need for gender-specific support strategies. We also
found significant associations between ATS use and the
use of other substances, which is in agreement with a
considerable body of evidence in the literature.35,36 Over
a third of Brazilian college students reported using two or
more substances in 2009, with amphetamine compounds
among the most consumed substances.7 Although pre-
senting large confidence intervals, our findings suggest
that ATS users in Brazil are up to 21 times more likely to
consume cocaine and almost 7 times more likely to use
cannabis than individuals who do not use ATS. The
strong association with cannabis is well documented, indi-
cating an overlapping of user profiles. This can be attri-
buted to user attempts to self-regulate the effects of ATS;
cannabis acts mainly as a sedative,37 alleviating some
of the undesirable effects of the stimulants. An associa-
tion between ATS use and cocaine use has also been
reported, due to similarities between user profile and use
context. Above all, we highlight the association found
between ATS use and socioeconomic status. Such a
relationship has been identified in other studies con-
ducted in Brazil7 and is supported by the fact that new
synthetic stimulants are still relatively expensive in Brazil
and other Latin American countries. Preliminary results
from the Global Drug Survey 2015 showed that the
average price of ecstasy in Brazil was h8.6 per pill and
h44.5 per gram,15 confirming unofficial sources that one
gram of MDMA can cost up to four times as much as the
same amount of cocaine in Brazil. Our results corroborate
this claim, showing that higher income increased the risk
of ATS use. This was also confirmed by the conditional
path model, in which this direct effect was moderated
by cocaine use (whether snorted or smoked). The same
relationship was not found with other illicit drugs, such
as cannabis. The conditional model also showed that
education level moderates the association between
income and ATS use: each additional year of schooling
reduces the direct effect between income and ATS use.
However, when cocaine use was concomitant, the asso-
ciation with education level ceased (i.e., education level
no longer decreased the chance of ATS use). Thus,
cocaine use moderates the association between income
and ATS use, magnifying the direct effect. This path
analysis is quite self-explanatory, providing a clear insight
into how such relationships can occur in a real-life
context. Its interpretation leads to the conclusion that
any attempts to prevent ATS use among risk groups
should always embrace the prevention of other drug use
and stress the harms of polydrug use. However, our
results also indicate that a higher education level reduces
the risk of ATS use in isolation (i.e., not combined with
other stimulants). It is therefore imperative to promote the
development of professional skills as protective measures
against drug use. Initiatives aimed at prevention are
efficient only when correctly targeted.38 Consequently, it
is of the utmost importance to target the vulnerable groups
identified in this study: young, affluent, poorly educated,
polydrug users, and, in the specific case of ATS, women.
The evidence presented here should help assess the impact
that ATS use has on the mental health care system in Brazil,
as well as provide a foundation for more efficient public
health policies and strategies.
The intrinsic limitations of this study should be men-
tioned. First, we used a cross-sectional design, which
demands a very careful interpretation of path analysis
models to avoid assumptions about causal relationships.
In addition, as in most assessments of illicit drug use,
we must consider the possibility that drug use was under-
reported. Furthermore, we must emphasize that the variety
of new synthetic stimulants is so broad that neither the
participant’s self-report nor even basic toxicology assess-
ments could precisely detect which type of stimulants
had actually been taken. To avoid misclassification, this
study grouped any non-prescribed stimulant into a single
category.
Table 2 Last-year use of amphetamine-type stimulants in
relation to sociodemographic characteristics and the use of
other substances*
Independent variable OR (95%CI) p-value
Sex
Male (n=1,719) 1.00
Female (n=2,109) 1.90 (0.71-5.10) 0.202
Age (n=3,828)
15-24 1.00
25-34 1.67 (0.45-6.24) 0.447
35-44 0.84 (0.19-3.82) 0.827
45-64 0.26 (0.04-1.54) 0.138
Years of schooling (n=3,788)
p 8 1.00
9-12 0.48 (0.16-1.43) 0.187
X 13 0.26 (0.07-0.99) 0.003
Marital status (n=3,828)
Married/cohabiting 1.00
Single/widowed/divorced 0.55 (0.18-1.68) 0.295
Personal income (n=2,338)
p 3 the MW 1.00
3-4 the MW 1.68 (0.39-7.34) 0.485
X 5 the MW 7.65 (2.04-28.60) 0.001
Work status (n=3,828)
Unemployed 1.00
Employed 1.70 (0.58-4.99) 0.334
Residence (n=3,398)
Urban 1.00
Rural 0.29 (0.03-2.25) 0.236
Other substance use
Alcohol abuse/dependence 3.23 (1.40-7.43) 0.006
Cannabis use 7.07 (2.46-20.31) 0.000
Cocaine/crack use 21.31 (7.42-61.23) 0.000
Other illicit drug use 7.68 (4.55-12.99) 0.000
95%CI = 95% confidence interval;
MW = Brazilian national minimum wage.
*Logistic regression models and sociodemographic variables were
mutually adjusted for age, sex, and education level.
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This study represents a major investigation of ATS-use
issues in a representative sample of the Brazilian popula-
tion, one of the largest developing countries in the world.
A cluster-like alignment of factors and events – a young
population, an emerging economy, and a shortfall in
mental health care and social services – has led to the
rise of this foreseeable (and preventable) public health
issue.
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